Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xcytrin and radiation therapy for childhood pontine glioma
NCT00387790Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Primary completion
- Apr 2010
- Countries
- 1
01
Overview
Phase 2, open-label trial of motexafin gadolinium in brainstem glioma, sponsored by National Cancer Institute. Primary endpoint: Event-free Survival at 1 year. Started Jun 2007; status: completed.
02
Drugs
motexafin gadolinium
03
Conditions
brainstem glioma
Beyond the preview
Go deeper on NCT00387790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387790.